{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T08:12:15Z","timestamp":1761293535866},"reference-count":53,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCO"],"published-print":{"date-parts":[[2001,2,1]]},"abstract":" PURPOSE: To determine the feasibility of an organ preservation regimen consisting of infusional paclitaxel administered concurrently with radiotherapy to patients with locally advanced head and neck squamous cell carcinoma (HNSCC). <\/jats:p> PATIENTS AND METHODS: Thirty-three previously untreated patients with stage III or IV tumors were enrolled onto the study. Paclitaxel was administered as a 120-hour continuous infusion every 3 weeks during the course of radiation therapy. Sixteen patients received a paclitaxel dose of 105 mg\/m2<\/jats:sup>, and 17 patients received 120 mg\/m2<\/jats:sup>. Radiation was delivered in a standard format at 1.8 Gy\/d to a total dose of 70.2 to 72 Gy. <\/jats:p> RESULTS: Three months after therapy, a 76% complete response (CR) at the primary site and a 70% overall CR was achieved. At 36 months, locoregional control was 55.7%, overall survival was 57.8%, and disease-free survival was 51.1%. The median survival duration for all 33 patients was greater than 50 months at the time of this report. Local toxicities including mucositis, dysphagia, and skin reactions were severe but tolerable. All patients retained functional speech, and all but four patients were swallowing food 3 months after treatment. Steady-state plasma concentrations for paclitaxel were not achieved during a 120-hour infusion, suggesting a nonlinear process. Tumor volume quantified by pretreatment computerized tomography imaging was associated with likelihood of response and survival. <\/jats:p> CONCLUSION: Paclitaxel administered as a 120-hour continuous infusion in combination with radiotherapy is a feasible and promising treatment for patients with advanced HNSCC. <\/jats:p>","DOI":"10.1200\/jco.2001.19.3.800","type":"journal-article","created":{"date-parts":[[2017,2,24]],"date-time":"2017-02-24T08:12:12Z","timestamp":1487923932000},"page":"800-811","source":"Crossref","is-referenced-by-count":43,"title":["Concurrent Paclitaxel and Radiation in the Treatment of Locally Advanced Head and Neck Cancer"],"prefix":"10.1200","volume":"19","author":[{"given":"John B.","family":"Sunwoo","sequence":"first","affiliation":[{"name":"From the Head and Neck Surgery Branch, National Institute of Deafness and Other Communication Disorders; Speech and Language Pathology Section, Rehabilitation Medicine Department, Clinical Center; and Branches of Radiation Oncology, Radiation Biology, Biometric Research, and Medicine, National Cancer Institute, National Institutes of Health, Bethesda, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurie L.","family":"Herscher","sequence":"additional","affiliation":[{"name":"From the Head and Neck Surgery Branch, National Institute of Deafness and Other Communication Disorders; Speech and Language Pathology Section, Rehabilitation Medicine Department, Clinical Center; and Branches of Radiation Oncology, Radiation Biology, Biometric Research, and Medicine, National Cancer Institute, National Institutes of Health, Bethesda, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenn S.","family":"Kroog","sequence":"additional","affiliation":[{"name":"From the Head and Neck Surgery Branch, National Institute of Deafness and Other Communication Disorders; Speech and Language Pathology Section, Rehabilitation Medicine Department, Clinical Center; and Branches of Radiation Oncology, Radiation Biology, Biometric Research, and Medicine, National Cancer Institute, National Institutes of Health, Bethesda, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovana R.","family":"Thomas","sequence":"additional","affiliation":[{"name":"From the Head and Neck Surgery Branch, National Institute of Deafness and Other Communication Disorders; Speech and Language Pathology Section, Rehabilitation Medicine Department, Clinical Center; and Branches of Radiation Oncology, Radiation Biology, Biometric Research, and Medicine, National Cancer Institute, National Institutes of Health, Bethesda, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank G.","family":"Ondrey","sequence":"additional","affiliation":[{"name":"From the Head and Neck Surgery Branch, National Institute of Deafness and Other Communication Disorders; Speech and Language Pathology Section, Rehabilitation Medicine Department, Clinical Center; and Branches of Radiation Oncology, Radiation Biology, Biometric Research, and Medicine, National Cancer Institute, National Institutes of Health, Bethesda, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dianne C.","family":"Duffey","sequence":"additional","affiliation":[{"name":"From the Head and Neck Surgery Branch, National Institute of Deafness and Other Communication Disorders; Speech and Language Pathology Section, Rehabilitation Medicine Department, Clinical Center; and Branches of Radiation Oncology, Radiation Biology, Biometric Research, and Medicine, National Cancer Institute, National Institutes of Health, Bethesda, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beth I.","family":"Solomon","sequence":"additional","affiliation":[{"name":"From the Head and Neck Surgery Branch, National Institute of Deafness and Other Communication Disorders; Speech and Language Pathology Section, Rehabilitation Medicine Department, Clinical Center; and Branches of Radiation Oncology, Radiation Biology, Biometric Research, and Medicine, National Cancer Institute, National Institutes of Health, Bethesda, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol","family":"Boss","sequence":"additional","affiliation":[{"name":"From the Head and Neck Surgery Branch, National Institute of Deafness and Other Communication Disorders; Speech and Language Pathology Section, Rehabilitation Medicine Department, Clinical Center; and Branches of Radiation Oncology, Radiation Biology, Biometric Research, and Medicine, National Cancer Institute, National Institutes of Health, Bethesda, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul S.","family":"Albert","sequence":"additional","affiliation":[{"name":"From the Head and Neck Surgery Branch, National Institute of Deafness and Other Communication Disorders; Speech and Language Pathology Section, Rehabilitation Medicine Department, Clinical Center; and Branches of Radiation Oncology, Radiation Biology, Biometric Research, and Medicine, National Cancer Institute, National Institutes of Health, Bethesda, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"McCullugh","sequence":"additional","affiliation":[{"name":"From the Head and Neck Surgery Branch, National Institute of Deafness and Other Communication Disorders; Speech and Language Pathology Section, Rehabilitation Medicine Department, Clinical Center; and Branches of Radiation Oncology, Radiation Biology, Biometric Research, and Medicine, National Cancer Institute, National Institutes of Health, Bethesda, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Rudy","sequence":"additional","affiliation":[{"name":"From the Head and Neck Surgery Branch, National Institute of Deafness and Other Communication Disorders; Speech and Language Pathology Section, Rehabilitation Medicine Department, Clinical Center; and Branches of Radiation Oncology, Radiation Biology, Biometric Research, and Medicine, National Cancer Institute, National Institutes of Health, Bethesda, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Muir","sequence":"additional","affiliation":[{"name":"From the Head and Neck Surgery Branch, National Institute of Deafness and Other Communication Disorders; Speech and Language Pathology Section, Rehabilitation Medicine Department, Clinical Center; and Branches of Radiation Oncology, Radiation Biology, Biometric Research, and Medicine, National Cancer Institute, National Institutes of Health, Bethesda, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suoping","family":"Zhai","sequence":"additional","affiliation":[{"name":"From the Head and Neck Surgery Branch, National Institute of Deafness and Other Communication Disorders; Speech and Language Pathology Section, Rehabilitation Medicine Department, Clinical Center; and Branches of Radiation Oncology, Radiation Biology, Biometric Research, and Medicine, National Cancer Institute, National Institutes of Health, Bethesda, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William D.","family":"Figg","sequence":"additional","affiliation":[{"name":"From the Head and Neck Surgery Branch, National Institute of Deafness and Other Communication Disorders; Speech and Language Pathology Section, Rehabilitation Medicine Department, Clinical Center; and Branches of Radiation Oncology, Radiation Biology, Biometric Research, and Medicine, National Cancer Institute, National Institutes of Health, Bethesda, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A.","family":"Cook","sequence":"additional","affiliation":[{"name":"From the Head and Neck Surgery Branch, National Institute of Deafness and Other Communication Disorders; Speech and Language Pathology Section, Rehabilitation Medicine Department, Clinical Center; and Branches of Radiation Oncology, Radiation Biology, Biometric Research, and Medicine, National Cancer Institute, National Institutes of Health, Bethesda, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James B.","family":"Mitchell","sequence":"additional","affiliation":[{"name":"From the Head and Neck Surgery Branch, National Institute of Deafness and Other Communication Disorders; Speech and Language Pathology Section, Rehabilitation Medicine Department, Clinical Center; and Branches of Radiation Oncology, Radiation Biology, Biometric Research, and Medicine, National Cancer Institute, National Institutes of Health, Bethesda, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carter","family":"Van Waes","sequence":"additional","affiliation":[{"name":"From the Head and Neck Surgery Branch, National Institute of Deafness and Other Communication Disorders; Speech and Language Pathology Section, Rehabilitation Medicine Department, Clinical Center; and Branches of Radiation Oncology, Radiation Biology, Biometric Research, and Medicine, National Cancer Institute, National Institutes of Health, Bethesda, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"233","reference":[{"key":"R1-084330","doi-asserted-by":"publisher","DOI":"10.3322\/canjclin.49.1.8"},{"key":"R2-084330","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199301213280306"},{"key":"R3-084330","unstructured":"Vokes EE: Combined-modality therapy of head and neck cancer. Oncology (Huntingt) 11: 27,1997-30,"},{"key":"R4-084330","doi-asserted-by":"publisher","DOI":"10.1097\/00001622-199805000-00007"},{"key":"R5-084330","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8588(05)70088-5"},{"key":"R6-084330","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8588(05)70091-5"},{"key":"R7-084330","unstructured":"Smith RE, Thornton DE, Allen J: A phase II trial of paclitaxel in squamous cell carcinoma of the head and neck with correlative laboratory studies. Semin Oncol 22: 41,1995-46,"},{"key":"R8-084330","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19980601)82:11<2270::AID-CNCR24>3.0.CO;2-Q"},{"key":"R9-084330","doi-asserted-by":"publisher","DOI":"10.1038\/277665a0"},{"key":"R10-084330","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.77.3.1561"},{"key":"R11-084330","doi-asserted-by":"publisher","DOI":"10.1126\/science.140.3566.490"},{"key":"R12-084330","unstructured":"Milas L, Milas MM, Mason KA: Combination of taxanes with radiation: Preclinical studies. Semin Radiat Oncol 9: 12,1999-26,"},{"key":"R13-084330","doi-asserted-by":"publisher","DOI":"10.3109\/00016489509139325"},{"key":"R14-084330","unstructured":"Leonard CE, Chan DC, Chou TC, et al: Paclitaxel enhances in vitro radiosensitivity of squamous carcinoma cell lines of the head and neck. Cancer Res 56: 5198,1996-5204,"},{"key":"R15-084330","unstructured":"Rosenthal DI, Carbone DP: Taxol plus radiation for head and neck cancer. J Infus Chemother 5: 46,1995-54,"},{"key":"R16-084330","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/86.6.441"},{"key":"R17-084330","unstructured":"Milas L, Hunter NR, Mason KA, et al: Enhancement of tumor radioresponse of a murine mammary carcinoma by paclitaxel. Cancer Res 54: 3506,1994-3510,"},{"key":"R18-084330","unstructured":"Milas L, Hunter NR, Mason KA, et al: Role of reoxygenation in induction of enhancement of tumor radioresponse by paclitaxel. Cancer Res 55: 3564,1995-3568,"},{"key":"R19-084330","unstructured":"Geard CR, Jones JM, Schiff PB: Taxol and radiation. J Natl Cancer Inst Monogr ( 15): 89,1993-94,"},{"key":"R20-084330","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1996.14.6.1877"},{"key":"R21-084330","doi-asserted-by":"publisher","DOI":"10.1007\/BF00944181"},{"key":"R22-084330","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1995.13.2.381"},{"key":"R23-084330","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.2.635"},{"key":"R25-084330","doi-asserted-by":"publisher","DOI":"10.1016\/0378-4347(93)80100-I"},{"key":"R26-084330","unstructured":"Seibel NL, Blaney SM, O\u2019Brien M, et al: Phase I trial of docetaxel with filgrastim support in pediatric patients with refractory solid tumors: A collaborative Pediatric Oncology Branch. National Cancer Institute and Children\u2019s Cancer Group trial. Clin Cancer Res 5: 733,1999-737,"},{"key":"R27-084330","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1993.11.11.2136"},{"key":"R28-084330","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.1995.01890020081015"},{"key":"R29-084330","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0347(199710)19:7<567::AID-HED2>3.0.CO;2-5"},{"key":"R30-084330","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.4.1318"},{"key":"R31-084330","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1994.12.12.2654"},{"key":"R32-084330","unstructured":"Ohtsu T, Sasaki Y, Tamura T, et al: Clinical pharmacokinetics and pharmacodynamics of paclitaxel: A 3-hour infusion versus a 24-hour infusion. Clin Cancer Res 1: 599,1995-606,"},{"key":"R33-084330","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1996.14.4.1071"},{"key":"R34-084330","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(97)00548-8"},{"key":"R35-084330","unstructured":"Robert F, Childs HA, Spencer SA, et al: Phase I\/IIa study of concurrent paclitaxel and cisplatin with radiation therapy in locally advanced non-small cell lung cancer: Analysis of early and late pulmonary morbidity. Semin Radiat Oncol 9: 136,1999-147,"},{"key":"R36-084330","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6690599"},{"key":"R38-084330","doi-asserted-by":"crossref","unstructured":"Turner SL, Slevin NJ, Gupta NK, et al: Radical external beam radiotherapy for 333 squamous carcinomas of the oral cavity: Evaluation of late morbidity and a watch policy for the clinically negative neck. Radiother Oncol 41: 21,1996-29,","DOI":"10.1016\/S0167-8140(96)91785-5"},{"key":"R39-084330","doi-asserted-by":"publisher","DOI":"10.1111\/j.1834-7819.1999.tb00220.x"},{"key":"R41-084330","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.1995.01890020024006"},{"key":"R42-084330","doi-asserted-by":"crossref","unstructured":"Smith RV, Krevitt L, Yi SM, et al: Early wound complications in advanced head and neck cancer treated with surgery and Ir 192 brachytherapy. Laryngoscope 110: 8,2000-12,","DOI":"10.1097\/00005537-200001000-00002"},{"key":"R43-084330","doi-asserted-by":"crossref","unstructured":"Tell R, Sjodin H, Lundell G, et al: Hypothyroidism after external radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 39: 303,1997-308,","DOI":"10.1016\/S0360-3016(97)00117-X"},{"key":"R44-084330","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(97)00116-8"},{"key":"R45-084330","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(98)00533-1"},{"key":"R46-084330","unstructured":"Steinberg L, Hassan M, Olmsted L, et al: A phase I trial of radiotherapy and simultaneous 24-hour paclitaxel in patients with locally advanced head and neck squamous cell carcinoma. Semin Oncol 24: S19-51,1997-S19-56,"},{"key":"R47-084330","unstructured":"Rosenthal DI, Sinard RJ, Okani O, et al: Seven-week continuous-infusion paclitaxel with concurrent radiotherapy for locally advanced head and neck squamous cell cancer: A phase I study. Semin Oncol 24: S19-67,1997-S19-71,"},{"key":"R48-084330","doi-asserted-by":"publisher","DOI":"10.1007\/BF00685842"},{"key":"R49-084330","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.11.3403"},{"key":"R50-084330","unstructured":"Hillman RE, Walsh MJ, Wolf GT, et al: Functional outcomes following treatment for advanced laryngeal cancer. Part I: Voice preservation in advanced laryngeal cancer. Part II: Laryngectomy rehabilitation: The state of the art in the VA System. Research Speech-Language Pathologists. Department of Veterans Affairs Laryngeal Cancer Study Group. Ann Otol Rhinol Laryngol Suppl 172: 1,1998-27,"},{"key":"R51-084330","unstructured":"Kearns CM, Gianni L, Egorin MJ: Paclitaxel pharmacokinetics and pharmacodynamics. Semin Oncol 22: 16,1995-23,"},{"key":"R52-084330","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1995.13.1.180"},{"key":"R53-084330","unstructured":"Hudes GR, Obasaju C, Chapman A, et al: Phase I study of paclitaxel and estramustine: Preliminary activity in hormone-refractory prostate cancer. Semin Oncol 22: 6,1995-11,"},{"key":"R54-084330","doi-asserted-by":"publisher","DOI":"10.1177\/000348948709600507"},{"key":"R55-084330","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(90)90562-X"},{"key":"R56-084330","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0347(199803)20:2<159::AID-HED10>3.0.CO;2-H"}],"container-title":["Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO.2001.19.3.800","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T21:49:36Z","timestamp":1653515376000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JCO.2001.19.3.800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,2,1]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,2,1]]}},"alternative-id":["10.1200\/JCO.2001.19.3.800"],"URL":"https:\/\/doi.org\/10.1200\/jco.2001.19.3.800","relation":{},"ISSN":["0732-183X","1527-7755"],"issn-type":[{"value":"0732-183X","type":"print"},{"value":"1527-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,2,1]]}}}